Molecular and Advanced Pathology Core:

Bringing Spatial “Omics” From Glass to Clinic

The Molecular and Advanced Pathology Core, established in 2021, aims to bridge the life sciences at UBC with clinical expertise at Vancouver General Hospital and BC Cancer to advance the translation of discoveries to improve prevention and treatment of diseases across the population. Using  multiplex Opal immunofluorescence from Akoya and new GeoMx Digital Spatial Profiling  from Nanostring technologies, MAPcore is committed to furthering the success of omics and other discovery research by translating these finding to clinical utility.

MAPcore is an affiliated core facility with University of British Columbia Department of Pathology & Laboratory Medicine, Vancouver Coastal Health Research Institute, and BC Cancer Research Institute.

We would like to acknowledge that the land on which we work is the territory of the Coast Salish Peoples, including the territories of
the xwməθkwəy̓əm (Musqueam), Skwxwú7mesh (Squamish), Stó:lō and Səl̓ílwətaʔ/Selilwitulh (Tsleil- Waututh) Nations.